Search Results

You are looking at 1 - 10 of 270 items for :

  • T regulatory cell x
  • Clinical Medicine x
Clear All
Open access

Yuting Wang

cells expressing IL-2 receptor alpha-chains(CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995, 155(3): 1151-1164. 8 Li F, Li Y, Wu S, et al . Distribution of Human Papilloma Virus High Risk Subtypes in Patients with Condyloma Acuminatum. Chinese Journal of Nosocomiology , 2012, 22 (1): 210-212. 9 Sun G. Relationship between Human Papillomavirus Infection and Regulatory T Lymphocyte and Helper T Cell 17 in Patients with Condyloma Acuminatum. Chinese Journal of Clinicians (Electronic Edition

Open access

Dragana Miloradovic, Dragica Miloradovic, Marina Gazdic Jankovic, Bojana Simovic Markovic, C. Randall Harrell, Crissy Fellabaum, Nebojsa Arsenijevic, Aleksandra Lukic and Vladislav Volarevic

between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017;23:1040-1050. 15. Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR,Fellabaum C, Djonov V, Arsenijevic N, Lukic ML, Volarevic V. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury. Liver Transpl. 2018;24:687-702. 16. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H, Lukic ML. Galectin-3 deficiency prevents

Open access

Ali Khalili, Soheil Ebrahimpour, Iradj Maleki, Saeid Abediankenari and Mousa Mohammadnia Afrouzi

, EBRAHIMPOUR S. Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis . Journal of biological regulators and homeostatic agents. 2016; 30 (3):675. 4. GRANT CR, LIBERAL R, MIELI-VERGANI G, VERGANI D, LONGHI MS. Regulatory T-cells in autoimmune diseases: challenges, controversies and—yet—unanswered questions . Autoimmunity reviews. 2015; 14 (2):105-16. 5. MOHAMMADNIA-AFROUZI M, ZAVARAN HOSSEINI A, KHALILI A, ABEDIANKENARI S, HOSSEINI V, MALEKI I. Decrease of CD4+ CD25+ CD127low FoxP3+ regulatory T cells with impaired

Open access

Earnest Oghenesuvwe Erhirhie, Chibueze Peter Ihekwereme and Emmanuel Emeka Ilodigwe

testing. Toxicol in Vitro 41 : 245–259. Hartung T, McBride M. (2011). Food for thought. on mapping the human toxome. ALTEX 28 : 83–93. Hartung T, Daston G. (2009). FORUM Are In Vitro Tests Suitable for Regulatory Use? Toxicol Sci 111 (2): 233–237. ICCVAM (2006). Test Method Evaluation Report – In Vitro Ocular Toxicity Test Methods for Identifying Ocular Severe Irritants and Corrosives. Inter-agency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program (NTP) Interagency Center for the

Open access

Jin Zhang

of extracellular and intracellular microbial infections and can defend against invasion of Brucella through cooperation with Th1 cells [ 12 ]. The antibody response to Brucella proteins, mediated by interleukin 17 (IL-17) secreted by Th17 cells, plays a key role in brucellosis vaccine [ 13 ]. Regulatory T cells (Tregs) inhibit the immune function of effector T cells, promoting Brucella invasion [ 14 ]. Therefore, the occurrence of brucellosis may be related to the imbalance in Treg/Th17 cells. Clapp et al. [ 15 ] have observed from nasal mucosa infection that

Open access

Evelina K. Vetskova, Mariya N. Muhtarova, Toma I. Avramov, Tsvetelina R. Stefanova, Ivan J. Chalakov and Maria H. Nikolova

;72(4):433-52. 4. Blumin JH, Handler EB, Simpson CB, et al. Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors. Ann Otol Rhinol Laryngol 2009;118(7):481-5. 5. Nikolova M, Lelievre JD, Carriere M, et al. Regulatory T cells modulate differentially the maturation and apoptosis of human CD8-T cell subsets. Blood 2009;113(19):4556-65. 6. Lohr J, Knoechel B, Caretto D, et al. Balance of Th1 and Th17 effector and peripheral regulatory T cells. Microbes Infect 2009;11(5):589-93. 7. Damyanov C, Terziev

Open access

M. Gulubova, J. Ananiev, M. Ignatova and K. Halacheva

;8(8):1032-1042. 23. Jia L, Wu C. The biology and functions of Th22 cells. In: T Helper Cell Differentiation and Their Function, 2014, vol. 841 of Advances in Experimental Medicine and Biology pp. 209-230. 24. Ma CS, Deenick EK, Batten M, Tangye SG. The origins, function, and regulation of T follicular helper cells. The Journal of Experimental Medicine 2012;209(7):1241-1253. 25. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775 - 787. 26. Numasaki M, Fukushi J-I, Ono M, Narula SK

Open access

Jovana Vojvodic, Goran Mihajlovic, Ana Andonov, Milos Markovic, Jelena Djordjevic and Petar Vojvodic

, Xiao B, Qiu W, Yang L, Hu B, Tian X et al. Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. J. Affect. Disord. 2010;124:68–75. 62. Bartrop RW, Luckhurst E, Lazarus L, Kiloh LG, Penny R. Depressed lymphocyte function after bereavement. Lancet 1977;1:834–36. 63. Eilat E, Mendlovic S, Doron A, Zakuth V, Spirer Z. Increased apoptosis in patients with major depression: a preliminary study. J. Immunol. 1999; 163: 533–34. 64. Baniyash M. Chronic inflammation, immunosuppression and

Open access

Milica Borovcanin, Ivan Jovanovic, Slavica Djukic Dejanovic, Gordana Radosavljevic, Nebojsa Arsenijevic and Miodrag L. Lukic

Psychiatry. 2003; 4(3): 119-23. 11. Korn T, Anderson AC, Bettelli E, Oukka M. The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J Neuroimmunol. 2007; 191(1-2): 51-60. 12. Abbas A, Lichtman AH, Pillai S. Cellular and Molecular Immunology, 6th Edition, Saunders, Elsevier, Philadelphia, USA, 2007. 13. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM

Open access

Matevz Skerget, Barbara Skopec, Darja Zontar and Peter Cernelc

marrow aplasia followed by delayed reconstitution of lymphocytes resulting in partial recovery on collection day. 11 As a consequence lower doses of lymphocytes are col lected and reinfused. There is accumulating evidence that the dose of infused lymphocytes and their recovery on day 15 and 30 after AHSCT are independent prognostic factors for overall survival in patients with non-Hodgkin lymphomas and myeloma. 12 - 15 Among lymphocyte subpopulations the CD16+/56+ natural killer (NK) cells are particularly strong independent predictors of survival. 12 T regulatory